HEAD AND NECK CANCER

This study tests a new immunotherapy drug (iparomlimab and tuvonralimab) combined with radiation and chemotherapy for people with advanced head and neck cancer that hasn't spread. The goal is to see if this combination can keep the cancer from coming back for at least one year. A…

This study tests whether a blood test that tracks tumor DNA can help doctors decide when to add short bursts of chemotherapy to standard immunotherapy for people with recurrent or metastatic head and neck cancer. About 30 adults will receive pembrolizumab (immunotherapy) plus occ…

This study tests a combination of the experimental drug volrustomig with standard chemotherapy (paclitaxel and carboplatin) in people with untreated, locally advanced HPV-negative head and neck cancer. After initial treatment, the next steps are tailored based on how well the tum…

This study tests a new drug called PC14586 (rezatapopt) in people with advanced solid tumors that have a specific TP53 Y220C mutation. The goal is to see if the drug is safe and shrinks tumors. About 300 adults whose cancer has worsened after prior treatment will take the drug al…

This early-phase study tests a new drug called ALX2004 in people with advanced lung, head and neck, colorectal, or esophageal cancers that have stopped responding to standard treatments. ALX2004 is an antibody-drug conjugate designed to deliver a toxic payload directly to cancer …

This study is for people whose head and neck cancer has come back after previous radiation. It tests whether giving a type of immunotherapy (pembrolizumab) along with either standard or proton radiation before surgery is safe and works better than surgery alone. About 40 adults w…

This study is testing a new approach for people with certain head and neck cancers: using lower doses of radiation and chemotherapy, followed by surgery to remove any remaining cancer in the neck. The goal is to see if this gentler treatment can still control the cancer while red…

This study tests whether a short course of antibiotics (metronidazole) and mouthwash (chlorhexidine) can lower the amount of bacteria living inside oral cancer tumors. About 30 adults scheduled for oral cancer surgery will receive the treatment before their operation. Researchers…

This study tests a drug called atezolizumab in about 200 adults with advanced solid tumors (like breast, lung, or colon cancer) whose tumor DNA suggests the drug might help. Participants get the same dose every 3 weeks, and researchers check if their cancer shrinks or stops growi…

This study tests a new combination of drugs and radiation for people whose head and neck cancer has returned after previous treatment. The goal is to find the safest dose and see how well the treatment works. About 30 participants will receive the drugs tislelizumab and pamiparib…

This study is for people with head and neck cancer. It compares two types of radiation therapy: one that treats only the cancer and nearby lymph nodes (INRT) and one that treats a larger area (ENI). The goal is to see if the smaller treatment area works just as well and causes fe…

This study tests an experimental drug called MCLA-129 in people with advanced solid tumors, including lung, head and neck, and colorectal cancers that have stopped responding to standard treatments. The drug is a bispecific antibody designed to target two cancer-related proteins …

This study tests whether adding two immunotherapy drugs (cemiplimab and cetuximab) to standard chemotherapy before surgery is safe and effective for people with advanced head and neck cancer. The goal is to see if this combination can help patients avoid needing radiation therapy…

This study looks at whether proton therapy can safely treat tumors that have returned after previous radiation. Unlike standard X-ray radiation, proton beams are more targeted and may spare healthy tissue. The trial will enroll 1,800 adults with various cancers to see if this app…

This study is testing whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for people with head and neck cancer that has come back or spread. The trial focuses on patients in rural Midwest areas, aiming to make treatment more acc…

This early-phase study tests a new treatment for advanced head and neck cancer that has stopped responding to standard therapies. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, designed to better target cancer cells and resist tumor def…

This study tests whether it is safe to skip radiation to the lymph nodes in the neck after surgery for early-stage oral cancer. About 396 adults aged 18-70 with certain high-risk features will be randomly assigned to receive or skip this radiation. The goal is to see if skipping …

This study tests giving chemotherapy and immunotherapy before standard surgery for head and neck cancer. The goal is to shrink tumors enough so that surgeons can do a less extensive operation, preserving speech, swallowing, and vision. About 75 adults with newly diagnosed, advanc…

This study is for people with advanced lung or head & neck cancers. It tests a new way of giving chemotherapy and immunotherapy (pembrolizumab) by alternating cycles. The goal is to see if this schedule helps patients complete more treatment cycles and improves cancer control. Ab…

This study looks at whether giving radiation therapy six days a week (instead of the usual five) can better control head and neck cancer in people who start treatment more than six weeks after surgery. About 75 adults with certain types of head and neck cancer will be randomly as…

This study is for people with HPV-related throat cancer who have had surgery. It tests whether a lower, personalized dose of radiation (and sometimes chemo) can control the cancer while causing fewer side effects and improving quality of life. About 111 adults will take part, and…

This early-phase trial tests a new drug called MDX2001 in about 285 adults with advanced solid tumors (cancers that have spread). The main goals are to check the drug's safety and find the right dose. Researchers will also see if it shrinks tumors. This is not a cure, but it may …

This study tests a program called ENDURE that helps head and neck cancer patients start radiation therapy within 6 weeks after surgery, as guidelines recommend. About 532 adults with certain types of head and neck cancer will take part. The program uses patient navigators to guid…

This early-stage trial tests whether using ultrasound and microbubbles can help deliver the immunotherapy drug pembrolizumab more effectively to tumors in people with recurrent or metastatic head and neck cancer. Six participants will receive three rounds of treatment. The main g…

This study looks at how well the drug T-DXd works for people with advanced HER2-positive solid tumors who have already tried other treatments and have no good options left. About 100 adults in the US will be followed to see if their tumors shrink or stop growing. The goal is to u…

This early-phase study tests an experimental drug called PF-08046876 in adults with advanced solid tumors (bladder, lung, head/neck, esophagus, or pancreatic cancer) that have not responded to standard treatments. The drug is an antibody-drug conjugate designed to stick to cancer…

This early-stage study tests a new drug called OCT-598 in about 51 adults with advanced solid tumors (breast, lung, prostate, head/neck, or stomach cancer). The main goals are to check safety, find the best dose, and see how the drug works alone or with standard treatments. Parti…

This study tests a combination of three drugs (carboplatin, paclitaxel, and cetuximab) in adults with head and neck cancer that has spread or returned and did not respond to first-line immunotherapy. The goal is to see if this second-line treatment can shrink tumors and control t…

This early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head/neck cancer. The main goal is to check safety and find the best dose. Participants receive the drug and are monitored for side effects a…

This study tests whether combining three treatments—modified natural killer cells (PD-L1 t-haNK), an immune-boosting protein (Anktiva), and a targeted antibody (cetuximab)—can shrink tumors in people with advanced head and neck cancer that has come back or spread. About 25 adults…

This early-stage study tests a new drug that delivers radiation directly to cancer cells. It is for people with advanced solid tumors like bladder, breast, lung, or cervical cancer that have not responded to prior treatments. The main goals are to find the safest dose and see if …

This study is for people with head and neck cancer that has returned after standard treatments. It tests a new therapy where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells. The main goals are to see if the treatment is safe and to f…

This early-phase study tests a new drug, VLPONC-01, injected directly into head and neck tumors to see if it's safe and can shrink tumors. About 41 adults with advanced head and neck cancer will receive the injection alone or with an immunotherapy drug (pembrolizumab). The goal i…

This study tests an experimental drug called patritumab deruxtecan in people with advanced solid tumors that have spread or cannot be removed. The drug targets a protein called HER3 found on some cancer cells. About 740 adults with various cancers like lung, breast, or melanoma w…

This study tests whether MRI scans can help doctors adjust radiation therapy for head and neck cancer patients to better target tumors while sparing healthy tissues. About 35 adults with squamous cell carcinoma will receive a personalized radiation boost based on MRI response. Th…

This study is testing a new treatment that uses a radioactive substance to target and destroy cancer cells in people with advanced solid tumors (like pancreatic, stomach, or ovarian cancer) that have not responded to standard treatments. The therapy works by attaching to a protei…

This program provides ulixertinib, an experimental drug, to adults with advanced solid tumors that have specific genetic changes (MAPK pathway mutations) and who have run out of standard treatments. The goal is to control the cancer, not cure it. Participants may take ulixertinib…

This study tests whether ongoing immune therapy can help prevent head and neck cancer from coming back in patients who already had a strong response to initial treatment. About 268 adults aged 18 to 80 with locally advanced head and neck cancer will receive immune maintenance the…

This study is testing whether a special type of MRI (DCE-MRI) can predict a serious side effect called osteoradionecrosis (jaw bone damage) in people with head and neck cancer who are receiving radiation therapy. Researchers will scan 1,400 participants before, during, and after …

This study is testing a new type of PET scan that targets a protein called Trop2, found on many solid tumors. The goal is to see if this scan can find and stage cancers like bladder, lung, liver, and ovarian cancer better than current methods. About 400 adults with confirmed or s…

This study tests a special dye called pegsitacianine that makes cancer cells glow during surgery. The goal is to help surgeons see and remove all cancer tissue in people with head and neck cancer, especially when the original tumor location is unknown. About 120 adults will recei…

This study tests whether a dye called panitumumab-IRDye800 can make head and neck cancer cells glow during surgery, helping surgeons see and remove them more accurately. About 25 adults with head and neck cancer who are already scheduled for surgery will receive the dye beforehan…

This study is testing a blood test that looks for DNA signals from 20 different cancers, including lung, breast, and colon cancer. Researchers will see if the test can find cancer early and tell which type it is. In people with lung cancer, the test will also check for any cancer…

This study is testing a new type of PET/CT scan that uses a special tracer called 18F-T2 to find cancers that have high levels of a protein called CAIX. About 200 adults with cancers like kidney, bladder, lung, or breast cancer will get this scan to see if it works better than th…

This study tests whether a near-infrared camera and a dye called indocyanine green can help surgeons spot tiny bits of cancer left behind during head and neck cancer surgery. About 65 adults with mouth or throat cancer will receive the dye before surgery, and the camera will scan…

This study is testing a special camera that uses a laser to take detailed pictures of mouth sores before surgery. The goal is to see if these pictures can help doctors find oral cancer cells without needing a biopsy. About 140 people with mouth cancer will have their sores photog…

This study tests whether a pill (apixaban) is a safe and more convenient alternative to a daily shot (enoxaparin) for preventing blood clots after head and neck cancer surgery. About 76 adults will take one of the two medicines for 10 days after surgery and complete surveys about…

This study looks at whether nerve transfer surgery can improve facial movement and quality of life for cancer patients who have facial paralysis after treatment. About 40 adults who are scheduled for this surgery will take part. Researchers will track side effects and measure cha…

This study tests a light-based treatment (photobiomodulation) to reduce chronic swelling in the head and neck area in people who have finished cancer treatment. About 150 survivors will receive either real or placebo light therapy to see if it eases their lymphedema. The goal is …

This study tests if a drug called Pedmark (sodium thiosulfate) can reduce hearing loss in adults receiving cisplatin chemotherapy for cancers like testicular, head and neck, or thoracic cancer. About 25 participants will receive Pedmark alongside their standard chemo. The goal is…

This study looks at whether closely watching jaw movement and starting physical therapy early can help prevent or reduce jaw tightness (trismus) in people with head and neck cancer who are getting radiation. About 30 participants will be tracked weekly during treatment and given …

This study tests whether extra nutrition support before and after surgery helps head and neck cancer patients maintain their weight. 60 adults having surgery will either get standard care or enhanced care with diet advice, follow-up calls, and monthly check-ins for 6 months. The …

This study tests whether starting a tongue strengthening exercise program soon after tongue cancer surgery can improve speech and swallowing. About 40 adults who have part of their tongue removed will use a biofeedback device called the Tongueometer to do the exercises. The goal …

This study tests whether a heavy lifting strength training program can help head and neck cancer survivors regain muscle strength, reduce fatigue, and improve quality of life. About 60 adults who finished cancer treatment at least one year ago will be randomly assigned to either …

This study tests whether a personalized program of exercise, nutrition advice, and counseling—started about 4 weeks before cancer treatment and continued through therapy—can help head and neck cancer patients maintain physical function, reduce malnutrition risk, and improve quali…

This study tests whether a virtual mind-body program called IM@Home can reduce fatigue and improve quality of life for adults with head and neck, thoracic, gynecologic, or other cancers who are receiving treatments like chemotherapy or radiation. About 480 participants will be en…

This study tests whether a special light treatment (photobiomodulation) can reduce swelling and tissue hardening caused by radiation therapy in head and neck cancer survivors. About 60 participants who completed radiation at least 3 months ago will receive either the light treatm…

This study tests whether a personalized exercise program using motion-controlled video games (like Nintendo Switch) can help head and neck cancer survivors reduce fatigue and pain after treatment. 150 participants who have finished radiation or chemotherapy will be assigned to ei…

This study tests a special gel and mouthwash (XCM-OM118) in 63 head and neck cancer patients getting radiation, with or without chemo. The goal is to see if it lowers the chance of severe mouth sores and improves quality of life. Patients use the product during radiation and late…

This study tests whether a program of nutrition counseling, guided exercise, and wellness education can help head and neck cancer patients undergoing chemoradiation feel better and stay stronger. Researchers will enroll 30 adults to see if the program is practical and helpful dur…

This pilot study tests if brodalumab, a drug approved for autoimmune diseases, can safely reduce severe side effects caused by cancer immunotherapy. About 11 adults with various solid tumors who have immune-related side effects will receive brodalumab. The goal is to see if it lo…

This study looks at whether a non-invasive, acupuncture-like electrical treatment (ALTENS) can reduce dry mouth in people who had radiation for head and neck cancer. About 75 adults who completed radiation at least 3 months ago and still have dry mouth will receive weekly session…

This study compares standard radiation therapy to a new 'dose-painting' method for people with head and neck cancer. The new approach gives higher radiation doses to the most active parts of the tumor while aiming to reduce severe side effects like mouth ulcers. About 100 partici…

This study tests whether a special light therapy (photobiomodulation) can improve dry mouth, swallowing, and overall quality of life in 60 head and neck cancer survivors who have completed radiation. Participants use a mobile health tool to track symptoms. The goal is to ease lon…

This study tests if atorvastatin, a common cholesterol drug, can reduce hearing loss caused by cisplatin chemotherapy in people with head and neck cancer. About 224 adults will either take atorvastatin or a placebo daily during and for 3 months after chemo. Hearing tests and bloo…

This study tests whether a special spa therapy can improve skin-related quality of life in people who have skin hardening (fibrosis) after radiation for breast or head/neck cancer. About 110 adults who finished radiation at least 6 months ago will be randomly assigned to get spa …

This study tests whether a structured physical activity program can help people with upper aerodigestive tract (head and neck) cancer reduce their sedentary time and increase physical activity over 18 months. About 96 adults with newly diagnosed, non-spreading cancer will be rand…

This study tests whether giving radiation only to high-risk areas after head and neck cancer surgery can reduce side effects without raising the chance of cancer coming back. About 50 adults with certain head and neck cancers will receive a personalized radiation plan. The goal i…

This study tests a new surgical technique using a skin flap from the groin area to rebuild the mouth or throat after cancer removal. The goal is to see if this method causes fewer complications at the donor site compared to standard flaps. About 40 adults with head and neck cance…

This study tests whether a special fruit cube (miracle fruit) can improve taste problems in people with head and neck cancer who are getting radiation therapy. About 40 participants will receive either the fruit cube or a placebo to see if it helps them taste food better and eat …

This study tests whether the drug riluzole can prevent memory and thinking problems (often called 'chemo brain') in people receiving chemotherapy for various cancers. About 24 adults with breast, lung, or other cancers will receive either riluzole or a placebo during their chemo.…

This study tests a new way to give radiation for head and neck cancer that may reduce dry mouth, a common and severe side effect. About 98 adults with oropharynx cancer will be randomly assigned to standard radiation or a technique guided by MRI that spares the saliva ducts. The …

This study tests a nurse-led program that helps head and neck cancer patients manage symptoms early during radiation therapy. The goal is to see if this approach reduces treatment interruptions compared to standard care. About 170 adults with head and neck cancer will take part. …

This study tests a chatbot called Digi-Coach to see if it can lower physical and emotional distress in people receiving radiation for head and neck cancer. About 138 adults will either use the chatbot plus standard care or just standard care. The chatbot lets patients ask questio…

This study tests a short video-based therapy called BRIGHT to help head and neck cancer survivors who feel distressed about changes in their appearance. About 180 survivors will be randomly assigned to BRIGHT or a supportive talk session. The goal is to see if BRIGHT reduces body…

This study looks at whether special training for caregivers of head and neck cancer patients can make a difference. After surgery, patients often have trouble breathing, eating, and speaking. The training teaches caregivers how to help with these needs so the patient can safely r…

This study tests a special cooling mouthpiece used during radiation therapy for larynx cancer. The goal is to see if cooling the mouth can prevent or reduce taste loss, a common side effect of radiation. About 15 adults with advanced larynx cancer will try the device and report c…

This study looks at whether giving fluoride varnish during regular cancer follow-up visits can help improve oral health for head and neck cancer patients who have had radiation and lack easy access to dental care. About 120 uninsured or underinsured adults will take part. Researc…

This study aims to find out if tiny particles in the blood, called extracellular vesicles, can predict nerve damage caused by chemotherapy. About 120 adults with certain cancers will give blood samples and answer questionnaires before, during, and after treatment. The goal is to …

This study looks at immune cells (T cells) in tumor samples from 1,100 people with cancers like head and neck, ovarian, cervical, lung, and brain cancer. Researchers want to understand how these cells behave, especially a protein called PD-1. No new treatments are tested—only sam…

This study looks at whether a 2-week exercise and nutrition program before head and neck cancer surgery is safe and doable. About 20 adults with a new head and neck cancer diagnosis will take part. The goal is to see if patients can complete the program and if they find it accept…

This study is testing a program called CARES that provides advocacy, resources, education, and support to rural cancer patients. The goal is to see if it helps them start treatment sooner and finish it on time. About 320 adults with solid tumors like lung, breast, or colon cancer…

This study looks at how the natural bacteria in your mouth might affect how well radiation therapy works for head and neck cancer. Researchers will collect saliva samples from 100 patients before, during, and after treatment to see if certain bacteria help control tumors or reduc…

This study looks at how to help head and neck cancer patients get nutritional counseling and exercise programs before and during radiation therapy. Researchers want to understand what helps or prevents patients from using these services. The goal is to make prehabilitation progra…

Some head and neck cancer survivors develop a condition called velopharyngeal dysfunction (VPD), where the soft palate doesn't close properly, causing nasal-sounding speech and trouble swallowing. This study with 20 adults will first measure how common and severe VPD is, then tes…

This study takes tumor samples from 120 people with head and neck cancer and grows them in the lab as mini tumors called organoids. Researchers will test different treatments on these organoids to see which ones work best, with the goal of choosing the most effective therapy for …

This study is testing whether a blood test that looks for tiny bits of tumor DNA (ctDNA) can find cancer early after treatment. Researchers will follow about 100 people with different solid tumors, plus healthy volunteers, to see if the test helps predict when cancer comes back. …

This study is testing a special PET-CT scanner that takes detailed pictures of cancer tissue right after it is removed during surgery. Researchers want to see if these images match the standard lab analysis and if they help doctors make better decisions. About 850 people with pro…

This study is collecting medical information and tissue samples from 350 adults with head and neck cancer at Samsung Medical Center. Researchers want to understand why some patients respond better to treatment than others. The goal is to find biological markers that can help doct…

This study looks at whether a simple blood test that finds leftover cancer cells (circulating tumor cells) can help doctors decide if oral cancer patients need extra chemotherapy after their usual treatment. About 100 people who have finished surgery and chemoradiation for oral c…

This study looks at how well people do after a second surgery (salvage surgery) for head and neck cancer that has come back or remained after initial treatment. Researchers will track survival and quality of life in 400 adults. They will also study tumor genetics to understand wh…

This study collects tumor samples from 2,000 people with various cancers to learn how to predict who will respond to immunotherapy. Participants donate tissue during a routine biopsy. The goal is to understand tumor biology and improve future treatment decisions, not to test a ne…

This study collects blood and leftover tissue samples from 9,600 adults with different types of cancer. Researchers will use these samples to develop and improve tests that detect cancer DNA in the blood, which may help monitor for cancer return or how well treatment is working. …

This study is testing new MRI techniques to get more detailed information about head and neck and thyroid tumors. Researchers will compare these new scans with standard follow-up data to see if they can better predict how a tumor responds to treatment. The study involves 200 adul…

This study looks at a nerve in the neck called the ansa cervicalis, which controls some throat muscles. Researchers want to measure its size and shape in 50 adults having neck surgery for head and neck cancer. They will also stimulate the nerve to see how much it moves the voice …

This study looks at why head and neck cancer sometimes comes back after radiation treatment. Researchers will collect tissue and blood samples from 20 people who need robotic surgery for their cancer. By comparing the original tumor with the one that returned, they hope to learn …

This study collects tissue, saliva, and blood samples from up to 8,000 people with head and neck cancer and healthy volunteers. The samples and medical information are stored in a repository to help researchers better understand the disease and improve future treatments. No direc…

This study collects sputum and tissue samples from 700 people with precancerous lung changes or certain cancers (lung, head and neck, esophageal). Researchers look for genetic markers that might help detect cancer earlier. The goal is to build a tissue bank for future research, n…

This study aims to identify new genes and proteins involved in head and neck cancer. By analyzing tissue from 500 patients undergoing surgery at Stanford, researchers hope to understand how the disease develops and progresses. The ultimate goal is to pave the way for better diagn…

This study is developing an AI method to track the movement of tumors and nearby organs during radiation therapy without using physical markers. Researchers will use data from 300 patients receiving radiation for various cancers or heart arrhythmias to train and test the system. …

This study aims to collect blood samples (liquid biopsies) from 2,500 people with cancer or at high risk for cancer. The samples will be stored and used in future research to better understand how cancers grow and respond to treatment. No new treatments are being tested; the goal…

This study collects blood, tumor, and other tissue samples from up to 1,250 people with head and neck, lung, or gastrointestinal cancers. The goal is to learn how the immune system changes during cancer treatments that affect immunity. Participants donate samples and fill out que…

This study looks at whether a simple blood test can tell which throat cancer patients can safely skip radiation after surgery. About 61 people with HPV-related throat cancer will have their blood tested before and after surgery. If the test is negative after surgery, they won't g…

This study is collecting blood, tissue, urine, and saliva from 7,000 people with many types of cancer to look for tiny bits of cancer DNA left after treatment. The goal is to find out if this DNA test can spot remaining cancer early and help doctors decide on next treatments. Par…

This study looks at why immunotherapy only helps about 15% of people with advanced head and neck cancer. Researchers will collect tissue and blood samples before and after treatment to find clues that predict who will benefit. The goal is to develop better, personalized treatment…

This study looks at how much Hispanic/Latinx head and neck cancer survivors know about lung cancer screening and what stops them from getting screened. Researchers will use surveys and interviews with about 44 people. The goal is to find ways to improve screening rates in this gr…

This early-phase study tests a small implantable device that delivers tiny amounts of different drugs directly into head and neck tumors. The goal is to see which drug works best for each person before full surgery. About 30 adults with certain head and neck cancers will take par…

This study is collecting tumor, blood, and plasma samples from over 1,000 people with certain cancers (ovarian, breast, head and neck, cervical, vulva, and sarcoma). The goal is to find new markers that link tumor genetics and immune response to how the disease behaves. Participa…

This study is testing a new tool to predict side effects from cancer treatment in elderly patients (70+) with advanced head and neck cancer. The goal is to see if the tool can help doctors choose safer treatments and improve outcomes. About 3 participants will be enrolled to vali…

This study monitors the nutritional health of 57 head and neck cancer patients during radiotherapy. Researchers regularly check body composition, muscle strength, food intake, and quality of life to spot early signs of malnutrition. The goal is to understand nutrition-related cha…

This study is building a large registry of people with rare head and neck cancers across Europe. Researchers will collect information from existing databases and doctors to understand how these cancers behave, what affects outcomes, and how well current treatments work. No new tr…

This study is a large registry that will follow 8,000 cancer patients who receive radiation therapy guided by an MR-Linac, a machine that combines an MRI scanner with a radiation beam. The goal is to see if this technology helps people live longer, controls tumors better, and imp…

This study tests whether giving head and neck cancer survivors a personalized survivorship care plan, along with a counseling session, helps them get better follow-up care. About 176 survivors will be randomly assigned to receive either the care plan or usual care. The goal is to…

This study looks at whether an imbalance in the natural bacteria in your mouth and gut (called dysbiosis) plays a role in head and neck cancer. Researchers will collect stool and saliva samples from 60 adults—some with cancer and some without—to compare their microbiomes. The goa…

This study looks at why cancer patients feel very tired during chemotherapy and radiation. Researchers will collect blood and stool samples from 125 adults with different cancers before, during, and after treatment. They aim to find links between fatigue and changes in genes and …